{"lastClose": 1.0800000429153442, "len": 494, "date": "2023-03-06", "alpha_1": -0.8842196398770834, "beta_1": 0.14655074168011975, "drawup_1": 0.7325581218050006, "natr_1": 33.97335852797722, "sup_1": -0.4777777888156745, "res_1": 0.0064814529669148975, "bullPattern_1": [], "bearPattern_1": ["LONGLINE"], "rsi_1": 57.59219145731187, "adx_1": 18.04105126377605, "drawdown_1": -0.9048152301462742, "stratHoldSharpe_1": -1.5172668359673975, "stratHoldAlpha_1": 249.89478600104158, "stratHoldDrawdown_1": -0.8385608891697468, "alpha_3mo": 1.8797835170807184, "beta_3mo": -0.4109531311225114, "drawup_3mo": 0.4117647223819081, "sharpe_3mo": -0.43862030695698495, "natr_3mo": 33.97335852797722, "sup_3mo": -0.13888889808713603, "res_3mo": 0.04629628709804908, "bullPattern_3mo": ["HAMMER"], "bearPattern_3mo": [], "rsi_3mo": 47.05882559185674, "adx_3mo": 52.941907114772626, "drawdown_3mo": -0.22018348824525358, "stratHoldSharpe_3mo": 0.21163566974498285, "stratHoldAlpha_3mo": 251.1203488722159, "stratHoldDrawdown_3mo": -0.19816513942072822, "Sector": "Health Care", "Industry": "Biotechnology: In Vitro & In Vivo Diagnostic Substances", "Market Cap": 267861626, "Country": "Cayman Islands", "Name": "LumiraDx Limited", "alpha%_1": 0.0037783807919459012, "beta%_1": 0.052619290152261126, "drawup%_1": 0.6863758837525044, "natr%_1": 1.0, "drawdown%_1": 0.002932027506118495, "stratHoldSharpe%_1": 0.01285699927454735, "stratHoldAlpha%_1": 3.6983588989105505e-06, "stratHoldDrawdown%_1": 0.0025423346044740063, "alpha%_3mo": 0.9038141801388697, "beta%_3mo": 0.009829575082414162, "drawup%_3mo": 0.8226083928818286, "sharpe%_3mo": 0.08153880355521254, "natr%_3mo": 1.0, "drawdown%_3mo": 0.16813825818129174, "stratHoldSharpe%_3mo": 0.35139558648580793, "stratHoldAlpha%_3mo": 0.3974831985448183, "stratHoldDrawdown%_3mo": 0.17746191212641804}